Skip to main content
2023 Annual Congress - Hybrid Main banner
Back
CE Evaluations View Session

Patient Safety

Guidelines for the Use of Neuromuscular Blocking Agents: A Clinical Update (1 Class A CE with 1 Pharm)

Monday, August 21, 2023
9:15 AM – 10:15 AM PDT
Location: CC Level 5- Ballroom 2
This session will focus on providing an overview of updates to clinical guidelines related to use of neuromuscular blocking agents during the delivery of anesthesia care. The presentation will utilize an expert panel to address monitoring of neuromuscular blockade, the use of neuromuscular blocking agents for surgical paralysis and airway management, and guidelines for the reversal of that blockade.

Supported by Merck Sharp & Dohme LLC

Learning Objectives:

  • Discuss monitoring considerations for patients who have received neuromuscular blocking agents.
  • Describe updates to clinical guidelines related to the administration of neuromuscular blocking agents during anesthesia.
  • Discuss clinical applications for the use of new guidelines related to the administration of neuromuscular blocking agents during anesthesia.